Hemogram-derived ratios as prognostic markers for major adverse cardiovascular events in patients with non-ST-segment elevation myocardial infarction

Table 6 Logistic regression predictive analysis regarding major adverse cardiovascular events-lethal outcome among patients with non-ST segment elevation myocardial infarction

Variable	OR	95%CI		P value
		Lower	Upper
CRP/Ly (T1) > 4.737	3.690	1.140	11.942	0.024
CRP/Ly (T2) > 22.3	2.839	0.835	9.650	0.095
NLPR (T2) > 0.021	2.780	0.751	10.285	0.126
NLR (T1) > 4.076	1.300	1.121	1.743	0.009
NLR (T2) > 4.667	4.915	1.917	12.602	0.001
PLR (T2) > 159.74	3.262	0.958	11.102	0.059
SII (T1) > 1745.18	2.642	0.650	10.743	0.175
SII (T2) > 1400.466	1.352	0.295	6.205	0.698

NLR: Neutrophil-to-lymphocyte ratio; NLPR: Neutrophil-to-lymphocyte and platelet ratio; PLR: Platelet-to-lymphocyte ratio; CRP/Ly: C-reactive protein-to-lymphocyte ratio; SII: Systemic immune inflammation index; T1: Analysis at admission; T2: Analysis after 24 hours; OR: Odds ratio.